drugset / Trial / NCT02661178
First in Man Clinical Trial of Emodepside (BAY 44-4400)
Phase 1
Completed
79 enrolled
Drugs for Neglected Diseases
Bayer · collabBill and Melinda Gates Foundation · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study will investigate the safety, tolerability, and pharmacokinetics of single ascending doses of emodepside (BAY 44-4400) in healthy male volunteers. This study will also conduct an exploratory investigation of the relative bioavailability of emodepside administered as tablets and determine the effect of food on the pharmacokinetics.
Timeline
- Start
- 2015-12
- Primary completion
- 2017-03-27
- Completion
- 2017-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emodepside | Small molecule | — | Oral |
Indications
No indication recorded.